A carregar...
Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open‐label, multicentre, 12‐week phase III study
AIM: We aimed to investigate the non‐inferiority of PA21 (sucroferric oxyhydroxide) to sevelamer hydrochloride (sevelamer) in terms of efficacy and safety in Japanese haemodialysis patients with hyperphosphataemia. METHODS: In this Phase III, open‐label, multicentre study, 213 haemodialysis patients...
Na minha lista:
| Publicado no: | Nephrology (Carlton) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347921/ https://ncbi.nlm.nih.gov/pubmed/27496336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nep.12891 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|